rituximab in A Sentence

    1

    Rituximab Now Approved in Italy!

    0
    2

    Rituximab Risk… FDA Review.

    0
    3

    Genentech is the drug company that produces Rituxan(Rituximab).

    0
    4

    Rituximab- for refractory skin and musculoskeletal disease.

    0
    5

    Rituximab resistance and transformation, February 2010 Newsletter, p. 9-10.

    0
    6

    Compromised immunity and maintenance Rituximab, Article 7, p. 28-29.

    0
    7

    In hairy cell leukemia, Rituximab is a commonly used monoclonal antibody.

    0
    8

    Rituximab is administered at a dose of 375mg/m 2 body surface area weekly for four weeks.

    0
    9

    Among them, Rituximab, trastuzumab, bevacizumab is a heavy product with a sales of $ 7 billion;

    0
    10

    She had never prescribed Rituximab before, but was committed to helping me get off of prednisone.

    0
    11

    Rheumatoid arthritis protocol- Two doses of Rituximab 1g is administered at an interval of 15 days.

    0
    12

    I feel like the information(on maintenance Rituximab) you made so freely available helped me dodge a bullet!

    0
    13

    Research study finds prolonged use of Rituximab heightens risk of suppressed long-term immunity, October 2011 Newsletter, p. 9-12.

    0
    14

    Immunoglobulins and maintenance Rituximab, Article 7, p. 26-29; September 2012 Newsletter, p. 3-8; November 2011 Newsletter, p. 2-5.

    0
    15

    Commentary on maintenance Rituximab from a prominent lymphoma specialist, January 2014 Newsletter, p. 17-18; September 2012 Newsletter, p. 4-6.

    0
    16

    Problems with maintenance Rituximab will likely also apply to Gazyva(obinutuzumab) and so called“biosimilars” to Rituximab that are now becoming available.

    0
    17

    Data: Top sellers TOP10 accounted for 3 seats, Rituximab, trastuzumab, bevacizumab three drug sales totaling more than 200 billion dollars.

    0
    18

    Problems with maintenance Rituximab will likely also apply to Gazyva(obinutuzumab) and so called“biosimilars” to Rituximab that are now becoming available.

    0
    19

    In response to many questions we get regarding maintenance Rituximab, we have prepared a summary of the pros and cons.

    0
    20

    If Rituximab were studied in pemphigus or pemphigoid, it may be eligible for orphan drug designation and all the incentives, including exclusivity.

    0
    21

    After much discussion with Dr. Williams, and a lot of reflective thought, we decided it was time to move ahead with Rituximab.

    0
    22

    I embarked on a series of Rituximab infusions ⎯ four over the past eight years ⎯ which have helped to control my symptoms.

    0
    23

    A course of Rituximab is administered with the hope that it will destroy all the B-cells that make antibodies in pemphigus or pemphigoid are removed.

    0
    24

    One example of this type of medication is Rituximab, which works specifically on the B cells- one of the many parts of the immune system.

    0
    25

    In recent years, Rituximab has demonstrated to be a generally well-tolerated and effective treatment that could be beneficial for a high number of pemphigus patients.

    0
    26

    Rituximab is currently one of the most popular treatments among P/P patients, and there is always lively discussion at the patient conference of its use in treatment.

    0
    27

    Approval was based on data from the Ritux 3 trial, a randomized, controlled trial conducted in France that used Roche-manufactured, European Union(EU)- approved Rituximab product as the clinical trial material.

    0
    28

    Mr. Baron was diagnosed with Pemphigus Vulgaris in 2005, he suffered from a severe and refractory case, but was lucky to reach remission after three years of treatment with Rituximab and IVIG.

    0
    29

    The FDA approval is based on data from the Ritux 3 trial, a Roche-supported, randomized, controlled trial conducted in France that used Roche-manufactured, European Union(EU)-approved Rituximab product as the clinical trial material.

    0
    30

    To get this treatment accessible to Italy's pemphigus patients, the Italian Pemphigus and Pemphigoid Association(ANPPI), issued a formal requested to the Italian Medicines Agency(AIFA) to include Rituximab in the list of medicines to administer at public hospitals.

    0